Table of Contents 1 Acquired Hemophilia Treatment Market Overview 1.1 Product Overview and Scope of Acquired Hemophilia Treatment 1.2 Classification of Acquired Hemophilia Treatment by Types 1.2.1 Global Acquired Hemophilia Treatment Revenue Comparison by Types (2019-2024) 1.2.2 Global Acquired Hemophilia Treatment Revenue Market Share by Types in 2018 1.2.3 Traditional Therapy 1.2.4 Advanced Therapy 1.3 Global Acquired Hemophilia Treatment Market by Application 1.3.1 Global Acquired Hemophilia Treatment Market Size and Market Share Comparison by Applications (2014-2024) 1.3.2 Hospitals 1.3.3 Clinic 1.3.4 Others 1.4 Global Acquired Hemophilia Treatment Market by Regions 1.4.1 Global Acquired Hemophilia Treatment Market Size (Million USD) Comparison by Regions (2014-2024) 1.4.1 North America (USA, Canada and Mexico) Acquired Hemophilia Treatment Status and Prospect (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) Acquired Hemophilia Treatment Status and Prospect (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Acquired Hemophilia Treatment Status and Prospect (2014-2024) 1.4.4 South America (Brazil, Argentina, Colombia) Acquired Hemophilia Treatment Status and Prospect (2014-2024) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Acquired Hemophilia Treatment Status and Prospect (2014-2024) 1.5 Global Market Size of Acquired Hemophilia Treatment (2014-2024) 2 Company Profiles 2.1 Baxalta, Inc. 2.1.1 Business Overview 2.1.2 Acquired Hemophilia Treatment Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Baxalta, Inc. Acquired Hemophilia Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.2 Genentech, Inc. 2.2.1 Business Overview 2.2.2 Acquired Hemophilia Treatment Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Genentech, Inc. Acquired Hemophilia Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.3 Baxter Healthcare Corporation 2.3.1 Business Overview 2.3.2 Acquired Hemophilia Treatment Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Baxter Healthcare Corporation Acquired Hemophilia Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.4 Sanofi SA 2.4.1 Business Overview 2.4.2 Acquired Hemophilia Treatment Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Sanofi SA Acquired Hemophilia Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.5 Bristol-Myers Squibb 2.5.1 Business Overview 2.5.2 Acquired Hemophilia Treatment Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Bristol-Myers Squibb Acquired Hemophilia Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.6 Ferring B.V. 2.6.1 Business Overview 2.6.2 Acquired Hemophilia Treatment Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Ferring B.V. Acquired Hemophilia Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.7 Novo Nordisk A/S 2.7.1 Business Overview 2.7.2 Acquired Hemophilia Treatment Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Novo Nordisk A/S Acquired Hemophilia Treatment Revenue, Gross Margin and Market Share (2017-2018) 3 Global Acquired Hemophilia Treatment Market Competition, by Players 3.1 Global Acquired Hemophilia Treatment Revenue and Share by Players (2014-2019) 3.2 Market Concentration Rate 3.2.1 Top 5 Acquired Hemophilia Treatment Players Market Share 3.2.2 Top 10 Acquired Hemophilia Treatment Players Market Share 3.3 Market Competition Trend 4 Global Acquired Hemophilia Treatment Market Size by Regions 4.1 Global Acquired Hemophilia Treatment Revenue and Market Share by Regions 4.2 North America Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) 4.3 Europe Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) 4.4 Asia-Pacific Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) 4.5 South America Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) 4.6 Middle East and Africa Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) 5 North America Acquired Hemophilia Treatment Revenue by Countries 5.1 North America Acquired Hemophilia Treatment Revenue by Countries (2014-2019) 5.2 USA Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) 5.3 Canada Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) 5.4 Mexico Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) 6 Europe Acquired Hemophilia Treatment Revenue by Countries 6.1 Europe Acquired Hemophilia Treatment Revenue by Countries (2014-2019) 6.2 Germany Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) 6.3 UK Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) 6.4 France Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) 6.5 Russia Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) 6.6 Italy Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) 7 Asia-Pacific Acquired Hemophilia Treatment Revenue by Countries 7.1 Asia-Pacific Acquired Hemophilia Treatment Revenue by Countries (2014-2019) 7.2 China Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) 7.3 Japan Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) 7.4 Korea Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) 7.5 India Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) 7.6 Southeast Asia Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) 8 South America Acquired Hemophilia Treatment Revenue by Countries 8.1 South America Acquired Hemophilia Treatment Revenue by Countries (2014-2019) 8.2 Brazil Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) 8.3 Argentina Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) 8.4 Colombia Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) 9 Middle East and Africa Revenue Acquired Hemophilia Treatment by Countries 9.1 Middle East and Africa Acquired Hemophilia Treatment Revenue by Countries (2014-2019) 9.2 Saudi Arabia Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) 9.3 UAE Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) 9.4 Egypt Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) 9.5 Nigeria Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) 9.6 South Africa Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) 10 Global Acquired Hemophilia Treatment Market Segment by Type 10.1 Global Acquired Hemophilia Treatment Revenue and Market Share by Type (2014-2019) 10.2 Global Acquired Hemophilia Treatment Market Forecast by Type (2019-2024) 10.3 Traditional Therapy Revenue Growth Rate (2014-2024) 10.4 Advanced Therapy Revenue Growth Rate (2014-2024) 11 Global Acquired Hemophilia Treatment Market Segment by Application 11.1 Global Acquired Hemophilia Treatment Revenue Market Share by Application (2014-2019) 11.2 Acquired Hemophilia Treatment Market Forecast by Application (2019-2024) 11.3 Hospitals Revenue Growth (2014-2019) 11.4 Clinic Revenue Growth (2014-2019) 11.5 Others Revenue Growth (2014-2019) 12 Global Acquired Hemophilia Treatment Market Size Forecast (2019-2024) 12.1 Global Acquired Hemophilia Treatment Market Size Forecast (2019-2024) 12.2 Global Acquired Hemophilia Treatment Market Forecast by Regions (2019-2024) 12.3 North America Acquired Hemophilia Treatment Revenue Market Forecast (2019-2024) 12.4 Europe Acquired Hemophilia Treatment Revenue Market Forecast (2019-2024) 12.5 Asia-Pacific Acquired Hemophilia Treatment Revenue Market Forecast (2019-2024) 12.6 South America Acquired Hemophilia Treatment Revenue Market Forecast (2019-2024) 12.7 Middle East and Africa Acquired Hemophilia Treatment Revenue Market Forecast (2019-2024) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

List of Tables and Figures Figure Acquired Hemophilia Treatment Picture Table Product Specifications of Acquired Hemophilia Treatment Table Global Acquired Hemophilia Treatment and Revenue (Million USD) Market Split by Product Type Figure Global Acquired Hemophilia Treatment Revenue Market Share by Types in 2018 Figure Traditional Therapy Picture Figure Advanced Therapy Picture Table Global Acquired Hemophilia Treatment Revenue (Million USD) by Application (2014-2024) Figure Acquired Hemophilia Treatment Revenue Market Share by Applications in 2018 Figure Hospitals Picture Figure Clinic Picture Figure Others Picture Table Global Market Acquired Hemophilia Treatment Revenue (Million USD) Comparison by Regions 2014-2024 Figure North America Acquired Hemophilia Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure Europe Acquired Hemophilia Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure Asia-Pacific Acquired Hemophilia Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure South America Acquired Hemophilia Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure Middle East and Africa Acquired Hemophilia Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure Global Acquired Hemophilia Treatment Revenue (Million USD) and Growth Rate (2014-2024) Table Baxalta, Inc. Basic Information, Manufacturing Base and Competitors Table Baxalta, Inc. Acquired Hemophilia Treatment Type and Applications Table Baxalta, Inc. Acquired Hemophilia Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Genentech, Inc. Basic Information, Manufacturing Base and Competitors Table Genentech, Inc. Acquired Hemophilia Treatment Type and Applications Table Genentech, Inc. Acquired Hemophilia Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Baxter Healthcare Corporation Basic Information, Manufacturing Base and Competitors Table Baxter Healthcare Corporation Acquired Hemophilia Treatment Type and Applications Table Baxter Healthcare Corporation Acquired Hemophilia Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Sanofi SA Basic Information, Manufacturing Base and Competitors Table Sanofi SA Acquired Hemophilia Treatment Type and Applications Table Sanofi SA Acquired Hemophilia Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors Table Bristol-Myers Squibb Acquired Hemophilia Treatment Type and Applications Table Bristol-Myers Squibb Acquired Hemophilia Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Ferring B.V. Basic Information, Manufacturing Base and Competitors Table Ferring B.V. Acquired Hemophilia Treatment Type and Applications Table Ferring B.V. Acquired Hemophilia Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors Table Novo Nordisk A/S Acquired Hemophilia Treatment Type and Applications Table Novo Nordisk A/S Acquired Hemophilia Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Global Acquired Hemophilia Treatment Revenue (Million USD) by Players (2014-2019) Table Global Acquired Hemophilia Treatment Revenue Share by Players (2014-2019) Figure Global Acquired Hemophilia Treatment Revenue Share by Players in 2017 Figure Global Acquired Hemophilia Treatment Revenue Share by Players in 2018 Figure Global Top 5 Players Acquired Hemophilia Treatment Revenue Market Share in 2018 Figure Global Top 10 Players Acquired Hemophilia Treatment Revenue Market Share in 2018 Figure Global Acquired Hemophilia Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019) Table Global Acquired Hemophilia Treatment Revenue (Million USD) by Regions (2014-2019) Table Global Acquired Hemophilia Treatment Revenue Market Share by Regions (2014-2019) Figure Global Acquired Hemophilia Treatment Revenue Market Share by Regions (2014-2019) Figure Global Acquired Hemophilia Treatment Revenue Market Share by Regions in 2018 Figure North America Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) Figure Europe Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) Figure Asia-Pacific Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) Figure South America Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) Figure Middle East and Africa Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) Table North America Acquired Hemophilia Treatment Revenue by Countries (2014-2019) Table North America Acquired Hemophilia Treatment Revenue Market Share by Countries (2014-2019) Figure North America Acquired Hemophilia Treatment Revenue Market Share by Countries (2014-2019) Figure North America Acquired Hemophilia Treatment Revenue Market Share by Countries in 2018 Figure USA Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) Figure Canada Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) Figure Mexico Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) Table Europe Acquired Hemophilia Treatment Revenue (Million USD) by Countries (2014-2019) Figure Europe Acquired Hemophilia Treatment Revenue Market Share by Countries (2014-2019) Figure Europe Acquired Hemophilia Treatment Revenue Market Share by Countries in 2018 Figure Germany Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) Figure UK Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) Figure France Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) Figure Russia Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) Figure Italy Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) Table Asia-Pacific Acquired Hemophilia Treatment Revenue (Million USD) by Countries (2014-2019) Figure Asia-Pacific Acquired Hemophilia Treatment Revenue Market Share by Countries (2014-2019) Figure Asia-Pacific Acquired Hemophilia Treatment Revenue Market Share by Countries in 2018 Figure China Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) Figure Japan Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) Figure Korea Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) Figure India Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) Figure Southeast Asia Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) Table South America Acquired Hemophilia Treatment Revenue by Countries (2014-2019) Table South America Acquired Hemophilia Treatment Revenue Market Share by Countries (2014-2019) Figure South America Acquired Hemophilia Treatment Revenue Market Share by Countries (2014-2019) Figure South America Acquired Hemophilia Treatment Revenue Market Share by Countries in 2018 Figure Brazil Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) Figure Argentina Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) Figure Colombia Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) Table Middle East and Africa Acquired Hemophilia Treatment Revenue (Million USD) by Countries (2014-2019) Table Middle East and Africa Acquired Hemophilia Treatment Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Acquired Hemophilia Treatment Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Acquired Hemophilia Treatment Revenue Market Share by Countries in 2018 Figure Saudi Arabia Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) Figure UAE Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) Figure Egypt Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) Figure Nigeria Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) Figure South Africa Acquired Hemophilia Treatment Revenue and Growth Rate (2014-2019) Table Global Acquired Hemophilia Treatment Revenue (Million USD) by Type (2014-2019) Table Global Acquired Hemophilia Treatment Revenue Share by Type (2014-2019) Figure Global Acquired Hemophilia Treatment Revenue Share by Type (2014-2019) Figure Global Acquired Hemophilia Treatment Revenue Share by Type in 2018 Table Global Acquired Hemophilia Treatment Revenue Forecast by Type (2019-2024) Figure Global Acquired Hemophilia Treatment Market Share Forecast by Type (2019-2024) Figure Global Traditional Therapy Revenue Growth Rate (2014-2019) Figure Global Advanced Therapy Revenue Growth Rate (2014-2019) Table Global Acquired Hemophilia Treatment Revenue by Application (2014-2019) Table Global Acquired Hemophilia Treatment Revenue Share by Application (2014-2019) Figure Global Acquired Hemophilia Treatment Revenue Share by Application (2014-2019) Figure Global Acquired Hemophilia Treatment Revenue Share by Application in 2018 Table Global Acquired Hemophilia Treatment Revenue Forecast by Application (2019-2024) Figure Global Acquired Hemophilia Treatment Market Share Forecast by Application (2019-2024) Figure Global Hospitals Revenue Growth Rate (2014-2019) Figure Global Clinic Revenue Growth Rate (2014-2019) Figure Global Others Revenue Growth Rate (2014-2019) Figure Global Acquired Hemophilia Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024) Table Global Acquired Hemophilia Treatment Revenue (Million USD) Forecast by Regions (2019-2024) Figure Global Acquired Hemophilia Treatment Revenue Market Share Forecast by Regions (2019-2024) Figure North America Acquired Hemophilia Treatment Revenue Market Forecast (2019-2024) Figure Europe Acquired Hemophilia Treatment Revenue Market Forecast (2019-2024) Figure Asia-Pacific Acquired Hemophilia Treatment Revenue Market Forecast (2019-2024) Figure South America Acquired Hemophilia Treatment Revenue Market Forecast (2019-2024) Figure Middle East and Africa Acquired Hemophilia Treatment Revenue Market Forecast (2019-2024)

Baxalta, Inc. Genentech, Inc. Baxter Healthcare Corporation Sanofi SA Bristol-Myers Squibb Ferring B.V. Novo Nordisk A/S